Guidelines adherence as a major protective aspect to increase survival rate in patients with candidaemia in Europe

Lancet Infect Dis. 2023 Jun;23(6):647-648. doi: 10.1016/S1473-3099(23)00046-4. Epub 2023 Feb 15.

Authors

Mohammad Sadegh Rezai¹, Fatemeh Ahangarkani²

Affiliations

¹ Pediatric Infectious Diseases Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 4815733971, Iran.
² Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari 4815733971, Iran. Electronic address: [email protected].

PMID: 37254299
DOI: 10.1016/S1473-3099(23)00046-4

No abstract available

Publication types

Comment

MeSH terms

Antifungal Agents / therapeutic use
Candida
Candidemia* / drug therapy
Europe / epidemiology
Humans
Retrospective Studies
Risk Factors
Survival Rate

Substances

Antifungal Agents